Florbetapir F-18 Patent Expiration
Florbetapir F-18 is Used for estimating beta-amyloid neuritic plaque density in adult patients with cognitive impairment. It was first introduced by Avid Radiopharmaceuticals Inc
Florbetapir F-18 Patents
Given below is the list of patents protecting Florbetapir F-18, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Amyvid | US7687052 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques | Apr 30, 2027 | Avid Radiopharms Inc |
| Amyvid | US8506929 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques | Apr 30, 2027 | Avid Radiopharms Inc |
Florbetapir F-18's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List